Session: Novel API Formulation and Delivery (2009 Annual Meeting)

Description:

This session will focus on the interaction between Active Pharmaceutical Ingredient (API) properties and formulation and delivery techniques required to achieve pharmaceutical benefit. We invite submissions on topics including but not limited to: API - excipient interactions, enhancement of API solubility, API surface, morphology or particle size effects, impact of API variability on its delivery, extended release delivery systems, processing strategies for property optimization.

Sponsor:

Pharmaceuticals

Chair:

Marylee Z. Southard
University of Kansas
Chemical & Petroleum Engrg. Dept.
1530 W. 15th Street, Room 4132
Lawrence, KS 66045
Phone Number: 785-864-3868
Fax Number: 785-864-4967
Email: marylee@ku.edu

Co-Chair:

Padma J. Narayan

Papers:

106a

Assessment of the Influence of Surface Modified Pharmaceutical Powders On Dissolution and Mechanical Properties of the Tablets
Lauren Beach, New Jersey Institute of Technology; Ajit Mujumdar, New Jersey Institute of Technology; Laila Jai Jallo, New Jersey Institute of Technology; Rajesh Davé, New Jersey Institute of Technology

106b

Simultaneous Microparticle Formation and Mixing in Supercritical CO2. Fast-Release Navirapine Drug Formulation
Ganesh Sanganwar, Auburn University; Sateesh K. Sathigari, Auburn University; Jayachandra Ramapuram, Auburn University; Ram B. Gupta, Auburn University

106d

Production of Pharmaceutical Nanoparticles Using An Environmentally-Safe Emulsion Template
Frank Romanski, Rutgers University; M. Silvina Tomassone, Rutgers University; Fernando J. Muzzio, Rutgers University; Paul Takhistov, Rutgers University

Break

106e

Therapeutic Antioxidant Polymers as a Potential Polymeric Material for Coating Medical Devices
Paritosh Wattamwar, University of Kentucky; Kevin Baldridge, University of Kentucky; Qunwei Zhang, University of Louisville; Thomas Dziubla, University of Kentucky

493h

Impact of Foam Quality On Granule Quality Attributes
Niranjan Kottala, Bristol-Myers Squibb Comany; Admassu Abebe, Bristol-Myers Squibb Comany; Paul Perioli, Bristol-Myers Squibb Comany; Robert Jerzewski, Bristol-Myers Squibb Comany

See more of this Group/Topical: Food, Pharmaceutical & Bioengineering Division

<< Previous Session | Next Session >>